Latest Drugs & Vaccines stories in Health, with AI-generated summaries from NewsSnap.ai.
A new comprehensive review published in The Lancet has affirmed the safety and effectiveness of mRNA vaccines for preventing infectious diseases. The study consolidates over two decades of research, including preclinical work, clinical trials, and post-market surveillance. It concludes that serious side effects are uncommon and the benefits of protection against severe illness, hospitalization, and mortality far outweigh any risks.
A recent report indicates that the Alzheimer's medication Leqembi could help over 75% of patients either maintain their current condition or experience improvement. This finding suggests a significant positive impact on the progression of the disease for a large number of individuals. The potential for improved patient outcomes offers a hopeful outlook for those affected by Alzheimer's.
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Novartis' Fabhalta (iptacopan) for adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression. This decision converts the drug's prior accelerated approval to full approval, based on two-year Phase 3 data demonstrating a significant slowing of kidney function decline, moving beyond reliance on a surrogate endpoint.